Outcomes of novel coronavirus disease 2019 (COVID-19) infection in 107 patients with cancer from Wuhan, China.

Hongyan ZhangLinwei WangYuanyuan ChenQiuji WuGaili ChenXiaokun ShenQun WangYouqin YanYi YuYahua ZhongXinghuan WangMatthew Chin Heng Chua Conghua Xie

Published in: Cancer (2020)

The results of the current study demonstrated that >50.0% of infected patients with cancer are susceptible to severe COVID-19. This risk is aggravated by simultaneous anticancer treatment and portends for a worse survival, despite treatment for COVID-19.

Keyphrases

coronavirus disease
sars cov
respiratory syndrome coronavirus
early onset
combination therapy
adipose tissue
free survival